Brain

ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene

Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s…

3 weeks ago

Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation

The appointment aligns with the company’s recent strategic pivot towards treating genetic disorders of the CNS without gene therapyGENEVA, June…

3 weeks ago

ApolloMD Taps 5 Healthcare Industry Leaders for Its Inaugural Strategic Advisory Board

ATLANTA, June 26, 2024 /PRNewswire/ -- ApolloMD, a leading provider of emergency medicine, hospitalist medicine, and revenue cycle management services…

3 weeks ago

Neurophet to present brain stimulation simulation study at OHBM 2024

- Presents a poster identifying tDCS effects for patients with AD and cognitively normal people - Showcases brain imaging treatment planning…

3 weeks ago

Groundbreaking Ecosystem Map Reveals Innovative Collaborations, Care Pathways, and Technologies for Dementia

CHICAGO, June 25, 2024 /PRNewswire/ -- A new Journal of Alzheimer's Disease article unveils an innovative tool demonstrating how key…

3 weeks ago

Linus Health Introduces Person-Centered Approach to Establish Clinically Meaningful Benefits and Personalized Brain Health Care

Scalable, systematic and automated process captures and monitors metrics based on patients' treatment priorities for managing Alzheimer's disease and related dementias…

3 weeks ago

Zeto Announces Winners of Clinical Trial Sponsorship Program

SANTA CLARA, Calif., June 25, 2024 /PRNewswire/ -- Zeto, Inc., an award-winning medical technology firm, is proud to announce the…

3 weeks ago

NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage

New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic stroke and ALSVancouver, British Columbia--(Newsfile…

3 weeks ago

Oragenics, Inc. Announces Pricing of Public Offering

SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal…

3 weeks ago

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat indications including skin, head &…

3 weeks ago